Moving experiences

Speeches

Improving Patient Outcomes: The Role of Medicines and the
Innovative Pharmaceutical Industry in An Integrated Health System
Speech by Jean-François Leprince, President, Aventis Pharma, Chairman, Canada's Research-Based Pharmaceutical Companies, (Rx&D)


OTTAWA (April 4, 2002) – Thank you Commissioner Romanow (and members of the Commission?) for allowing us to present our views on the future of health care in Canada. My name is Jean-François Leprince and I am President of Aventis Pharma and Chair of the Board of Directors of Rx&D. With me today is Murray Elston, President of Rx&D, the national association representing over 21,000 employees who work for Canada's 63 research-based pharmaceutical companies.

While several proposals are being put forth on the future of health care in this country, we are of the firm opinion that patient health outcomes should be the paramount consideration in the development of government health policy and the delivery of health serv...